Crossmark

Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration

Crossref DOI link: https://doi.org/10.1007/s40123-022-00645-1

Published Online: 2023-01-06

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kaiser, Peter K. https://orcid.org/0000-0001-5126-045X
Yun, Jihoon https://orcid.org/0000-0002-2246-6077
Kim, Soyeon https://orcid.org/0000-0003-4921-8740
Kim, Jihyun https://orcid.org/0000-0001-8971-7857
Park, Su Jin https://orcid.org/0000-0002-6025-3160
Funding

Funding for this research was provided by:

Samsung Bioepis Co., Ltd.
License Information

Text and Data Mining valid from 2023-01-06

Version of Record valid from 2023-01-06
More Information

Article History

Received: 9 November 2022

Accepted: 21 December 2022

First Online: 6 January 2023